Prochlorperazine
DrugBank ID: DB00433
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| schizophrenia | 1.0000 | DL |
| retinal dystrophy with or without extraocular anomalies | 1.0000 | DL |
| hydranencephaly (disease) | 1.0000 | DL |
| congenital disorder of glycosylation with defective fucosylation | 1.0000 | DL |
| myopia X-linked | 1.0000 | DL |
| Charcot-Marie-Tooth disease, demyelinating, type 1G | 1.0000 | DL |
| polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis | 1.0000 | DL |
| syndromic myopia | 1.0000 | DL |
| myopia 26, X-linked, female-limited | 1.0000 | DL |
| atypical glycine encephalopathy | 1.0000 | DL |
| manic bipolar affective disorder | 0.9998 | DL |
| distal 17p13.3 microdeletion syndrome | 0.9985 | DL |
| hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome | 0.9977 | DL |
| bipolar disorder | 0.9967 | DL |
| schizophreniform disorder | 0.9961 | DL |
| attention deficit hyperactivity disorder, inattentive type | 0.9950 | DL |
| major affective disorder | 0.9946 | DL |
| attention deficit-hyperactivity disorder | 0.9940 | DL |
| psychotic disorder | 0.9934 | DL |
| Phelan-McDermid syndrome | 0.9920 | DL |
| early-onset schizophrenia | 0.9917 | DL |
| specific developmental disorder | 0.9914 | DL |
| treatment-refractory schizophrenia | 0.9912 | DL |
| Malan overgrowth syndrome | 0.9876 | DL |
| REM sleep behavior disorder | 0.9873 | DL |
| faciodigitogenital syndrome | 0.9867 | DL |
| psychosexual disorder | 0.9849 | DL |
| chondromyxoid fibroma | 0.9804 | DL |
| trichotillomania | 0.9792 | DL |
| mental disorder | 0.9747 | DL |
| tic disorder | 0.9661 | DL |
| autism susceptibility 1 | 0.9575 | DL |
| enuresis | 0.9545 | DL |
| dissociative disorder | 0.9528 | DL |
| autism spectrum disorder | 0.9514 | DL |
| factitious disorder | 0.9496 | DL |
| childhood apraxia of speech | 0.9466 | DL |
| asperger syndrome, susceptibility to | 0.9437 | DL |
| gaze palsy, familial horizontal, with progressive scoliosis | 0.9433 | DL |
| striatal degeneration, autosomal dominant | 0.9431 | DL |
| skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome | 0.9427 | DL |
| neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive | 0.9412 | DL |
| postpartum psychosis | 0.9371 | DL |
| amelocerebrohypohidrotic syndrome | 0.9303 | DL |
| substance-induced psychosis | 0.9268 | DL |
| communication disorder | 0.9242 | DL |
| fetal nicotine spectrum disorder | 0.9233 | DL |
| stereotypic movement disorder | 0.9233 | DL |
| developmental disorder of mental health | 0.9219 | DL |
| Tourette syndrome | 0.9182 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.